Does your strategy team get stuck in "analysis paralysis"?Or do you write strategic plans and then can't implement them?These are symptoms of astrategia, better known as strategy blindness. It's a common problem in pharma and medtech companies, caused by the necessary cognitive and professional diversity in your team.Common, but fixable if you understand the problem. And by then end of this short video, you will.This video is a summary of "Astrategia", an article published in PME magazine. If you would like a PDF of that article, please comment on the video and mail me at [email protected]